Teresa Ruiz, MD | |
2062 Lebanon Rd, Crawfordsville, IN 47933-2143 | |
(765) 362-7337 | |
(765) 362-7141 |
Full Name | Teresa Ruiz |
---|---|
Gender | Female |
Speciality | Pediatrics |
Location | 2062 Lebanon Rd, Crawfordsville, Indiana |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1063493005 | NPI | - | NPPES |
200532100 | Medicaid | IN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208000000X | Pediatrics | 01061195A (Indiana) | Primary |
Mailing Address | Practice Location Address |
---|---|
Teresa Ruiz, MD 2605 N Lebanon St, Lebanon, IN 46052-1476 Ph: () - | Teresa Ruiz, MD 2062 Lebanon Rd, Crawfordsville, IN 47933-2143 Ph: (765) 362-7337 |
News Archive
BeaconEquity.com announces an investment report featuring Cell Therapeutics Inc. The report includes financial, comparative and investment analyses, and pertinent industry information you need to know to make an educated investment decision.
The Spine Patient Outcomes Research Trial (SPORT) is the first comprehensive study to look at the effectiveness of different treatments for low back and leg pain. It was designed to provide data and outcomes to guide doctors and their patients in their treatment choices for three common spinal disorders: intervertebral disk herniation (IDH), degenerative spondylolisthesis (DS), and lumbar spinal stenosis (LSS).
Now, a team of scientists at the United Kingdom's Rosalind Franklin Institute may have a surprising solution for the coronavirus pandemic, which has killed more than 574,000 people worldwide.
Sangamo BioSciences, Inc. announced today that research led by Donald B. Kohn, M.D., Professor of Microbiology, Immunology and Molecular Genetics (MIMG) and Pediatrics, the Director of the UCLA Human Gene Medicine Program and member of the Broad Stem Cell Research Center, and Philip Gregory, D. Phil., Sangamo's chief scientific officer and vice president, research, has been selected to receive a $486,000 Doris Duke Innovations in Clinical Research Award from the Doris Duke Charitable Foundation.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced initiation of the PROstate Advanced Cancer Treatment (PROACT) Phase 2 proof-of-concept clinical trial to evaluate the efficacy and safety of bafetinib in patients with advanced prostate cancer.
› Verified 2 days ago
Anita Joshi, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1901 Lafayette Rd, Suite 200, Crawfordsville, IN 47933 Phone: 765-361-3086 Fax: 765-361-3088 | |
Dr. Hemangini Malaykumar Trivedi, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 16 Copperleaf Dr, Crawfordsville, IN 47933 Phone: 317-373-0891 Fax: 765-364-9740 |